Urticaria associated with hyper-IgE in a patient with psoriasis undergoing treatment with efalizumab

Acta Derm Venereol. 2009;89(4):412-3. doi: 10.2340/00015555-0613.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • CD11 Antigens / immunology*
  • Etanercept
  • Humans
  • Immunoglobulin E / blood*
  • Immunoglobulin G / administration & dosage
  • Male
  • Middle Aged
  • Psoriasis / drug therapy*
  • Receptors, Tumor Necrosis Factor / administration & dosage
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Urticaria / blood*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • CD11 Antigens
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Immunoglobulin E
  • Etanercept
  • efalizumab